Cargando…
Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
BACKGROUND: Microphthalmia Transcription Factor (MITF)family translocation renal cell carcinoma (tRCC) is a rare RCC subtype harboring TFE3/TFEB translocations. The prognosis in the metastatic (m) setting is poor. Programmed death ligand-1 expression was reported in 90% of cases, prompting us to ana...
Autores principales: | Boilève, A., Carlo, M. I., Barthélémy, P., Oudard, S., Borchiellini, D., Voss, M. H., George, S., Chevreau, C., Landman-Parker, J., Tabone, M-D, Chism, D. D., Amin, A., Bilen, M. A., Bosse, D., Coulomb-L’hermine, A., Su, Xiaoping, Choueiri, T. K., Tannir, Nizar M., Malouf, Gabriel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307255/ https://www.ncbi.nlm.nih.gov/pubmed/30591082 http://dx.doi.org/10.1186/s40425-018-0482-z |
Ejemplares similares
-
Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions
por: Thouvenin, Jonathan, et al.
Publicado: (2021) -
The scientific method: pillar and pitfall of cancer research
por: Tu, Shi-Ming, et al.
Publicado: (2014) -
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
por: Thouvenin, Jonathan, et al.
Publicado: (2022) -
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022) -
Partial Rescue of Ocular Pigment Cells and Structure by Inducible Ectopic Expression of Mitf-M in MITF-Deficient Mice
por: Michael, Helen T., et al.
Publicado: (2018)